Cas:924869-13-6 2-(5-bromopyridin-3-yl)-1,3,4-oxadiazole manufacturer & supplier

We serve Chemical Name:2-(5-bromopyridin-3-yl)-1,3,4-oxadiazole CAS:924869-13-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-(5-bromopyridin-3-yl)-1,3,4-oxadiazole

Chemical Name:2-(5-bromopyridin-3-yl)-1,3,4-oxadiazole
CAS.NO:924869-13-6
Synonyms:3-bromo-5-(1,3,4-oxadiazol-2-yl)pyridine;bromooxadiazolylpyridine
Molecular Formula:C7H4BrN3O
Molecular Weight:226.03000
HS Code:2934999090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:51.81000
Exact Mass:224.95400
LogP:1.89410

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 3-bromo-5-(1,3,4-oxadiazol-2-yl)pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,bromooxadiazolylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,bromooxadiazolylpyridine Use and application,3-bromo-5-(1,3,4-oxadiazol-2-yl)pyridine technical grade,usp/ep/jp grade.


Related News: Charles River Ballina, through the Corporate Citizenship programme, has continued to support worthwhile causes in the local community and has funded a number of organizations, including the Mayo Roscommon Hospice, the River Moy Search & Rescue and the Ballina Community Clean Up Volunteer Organisation who have helped develop a local sensory garden. 6-(2-(4-((1-(furan-2-ylmethyl)-1H-benzo[d]imidazol-2-yl)amino)piperidin-1-yl)ethyl)-3,7-dimethyl-5H-thiazolo[3,2-a]pyrimidin-5-one manufacturers Japan on Friday approved the administration of AstraZeneca Plc’s (AZN.L) COVID-19 vaccine after a few months’ pause due to fears about potential side effects, local media reported. (1R)-cyclohept-2-en-1-ol suppliers There are limited treatment options for the disorder. Women with advanced endometrial cancer who are not candidates for curative therapy have a survival rate of just 17% 3-methyl-benzo[1,4]thiazin-2-one O-benzoyl-oxime vendor & factory.